[HTML][HTML] Forkhead box proteins: tuning forks for transcriptional harmony
EWF Lam, JJ Brosens, AR Gomes, CY Koo - Nature Reviews Cancer, 2013 - nature.com
Forkhead box (FOX) proteins are multifaceted transcription factors that are responsible for
fine-tuning the spatial and temporal expression of a broad range of genes both during …
fine-tuning the spatial and temporal expression of a broad range of genes both during …
FOXM1 and cancer: faulty cellular signaling derails homeostasis
D Kalathil, S John, AS Nair - Frontiers in oncology, 2021 - frontiersin.org
Forkhead box transcription factor, FOXM1 is implicated in several cellular processes such as
proliferation, cell cycle progression, cell differentiation, DNA damage repair, tissue …
proliferation, cell cycle progression, cell differentiation, DNA damage repair, tissue …
[HTML][HTML] Integrated genomic analyses of ovarian carcinoma
Cancer Genome Atlas Research Network - Nature, 2011 - ncbi.nlm.nih.gov
Summary The Cancer Genome Atlas (TCGA) project has analyzed mRNA expression,
miRNA expression, promoter methylation, and DNA copy number in 489 high-grade serous …
miRNA expression, promoter methylation, and DNA copy number in 489 high-grade serous …
The same, only different–DNA damage checkpoints and their reversal throughout the cell cycle
IA Shaltiel, L Krenning, W Bruinsma… - Journal of cell …, 2015 - journals.biologists.com
Cell cycle checkpoints activated by DNA double-strand breaks (DSBs) are essential for the
maintenance of the genomic integrity of proliferating cells. Following DNA damage, cells …
maintenance of the genomic integrity of proliferating cells. Following DNA damage, cells …
FOX (M1) news—it is cancer
M Halasi, AL Gartel - Molecular cancer therapeutics, 2013 - AACR
FOXM1 is an oncogenic transcription factor of the Forkhead family and it has a well-defined
role in cell proliferation and cell-cycle progression. Expression of FOXM1 is excluded in …
role in cell proliferation and cell-cycle progression. Expression of FOXM1 is excluded in …
FOXM1: a multifunctional oncoprotein and emerging therapeutic target in ovarian cancer
Simple Summary Ovarian cancer is a lethal disease in women with a 10-year survival rate
of< 40% worldwide. A key molecular alteration in ovarian cancer is the aberrant …
of< 40% worldwide. A key molecular alteration in ovarian cancer is the aberrant …
Multiple faces of FoxM1 transcription factor: lessons from transgenic mouse models
TV Kalin, V Ustiyan, VV Kalinichenko - Cell cycle, 2011 - Taylor & Francis
FoxM1 transcription factor (previously called HFH-11B, Trident, FoxM1b, Win, and MPP2) is
expressed in actively dividing cells and critical for cell cycle progression. FoxM1 expression …
expressed in actively dividing cells and critical for cell cycle progression. FoxM1 expression …
The transcription factor FOXM1 (Forkhead box M1): proliferation-specific expression, transcription factor function, target genes, mouse models, and normal biological …
I Wierstra - Advances in cancer research, 2013 - Elsevier
Abstract FOXM1 (Forkhead box M1) is a typical proliferation-associated transcription factor,
which stimulates cell proliferation and exhibits a proliferation-specific expression pattern …
which stimulates cell proliferation and exhibits a proliferation-specific expression pattern …
FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and …
I Wierstra - Advances in cancer research, 2013 - Elsevier
Abstract FOXM1 (Forkhead box M1) is a typical proliferation-associated transcription factor
and is also intimately involved in tumorigenesis. FOXM1 stimulates cell proliferation and cell …
and is also intimately involved in tumorigenesis. FOXM1 stimulates cell proliferation and cell …
Nanoparticle delivery systems with cell-specific targeting for pulmonary diseases
Respiratory disorders are among the most important medical problems threatening human
life. The conventional therapeutics for respiratory disorders are hindered by insufficient drug …
life. The conventional therapeutics for respiratory disorders are hindered by insufficient drug …